The Board of Directors of Exalt AB (publ) initiates review of strategic alternatives to maximize shareholder value and publishes forecast for 2025 and financial targets for 2026
The Board of Directors of Exalt AB (publ) (“Exalt” or the “Company”) has today decided to initiate a process to evaluate Exalt’s different alternatives to maximize shareholder value. As part of this process, the Board intends to consider all strategic options, which may include a sale of the Company or other possible transactions. In connection with the review, the Company also publishes a forecast for the fourth quarter and full year 2025 as well as financial targets for 2026.The Board has engaged Redeye, a leading Nordic investment bank focused on Tech, Industrials, and Life Science, as